Emerging Biomarker-Guided Therapies in Prostate Cancer

Emerging Biomarker-Guided Therapies in Prostate Cancer

Prostate cancer remains one of the leading causes of cancer death in men worldwide. In the past decade, several new treatments for advanced prostate cancer have been approved. With a wide variety of available drugs, including cytotoxic agents, androgen receptor axis-targeted therapies, and alpha-emi...

Full description

Bibliographic Details
Main Authors: Jasna E. Deluce, Luisa Cardenas, Aly-Khan Lalani, Saman Maleki Vareki, Ricardo Fernandes
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Current Oncology
Subjects:
prostate cancer
predictive biomarkers
immunotherapy
theranostics
PARP inhibitors
Online Access:https://www.mdpi.com/1718-7729/29/7/400

Internet

https://www.mdpi.com/1718-7729/29/7/400

Similar Items